{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-24-007395","form_type":"8-K","ticker":"NAUT","cik":"0001808805","company_name":"Nautilus Biotechnology, Inc.","filed_at":"2024-02-28T23:59:59+00:00","discovered_at":"2026-05-14T18:03:25.614648+00:00","generated_at":"2026-06-05T09:19:53.161103+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Nautilus Biotechnology enters $125M at-the-market equity offering with TD Cowen","bullets":["Sales agreement with TD Cowen to sell up to $125M of common stock via ATM program.","TD Cowen will receive up to 3.0% of gross proceeds as compensation.","Company may set sale parameters including price, volume, and timing; no obligation to sell.","Shares issued under S-3 registration statement filed Feb 28, 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-24-007395","json":"https://secwatch.observer/filing/0001628280-24-007395.json","markdown":"https://secwatch.observer/filing/0001628280-24-007395.md","text":"https://secwatch.observer/filing/0001628280-24-007395.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1808805/000162828024007395/0001628280-24-007395-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1808805/000162828024007395/naut-20240228.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-05T09:19:53.161103+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"baa0751d060f2b12bd4b92dfd37708b088f5ab4e","claim":"Nautilus Biotechnology, Inc. entered into Sales Agreement with Cowen and Company, LLC valued at $125,000,000 (effective 2024-02-28).","evidence_excerpt":"On February 28, 2024, Nautilus Biotechnology, Inc. (the “Company”) entered into a Sales Agreement (the “Sales Agreement”) with Cowen and Company, LLC (“TD Cowen”) to sell shares of the Company’s common stock, par value $0.0001 per share (the “Common Stock”), having aggregate sales proceeds of up to $125,000,000","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1808805/000162828024007395/0001628280-24-007395-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"atm program"},{"label":"Counterparty","value":"Cowen and Company, LLC"},{"label":"Value","value":"$125,000,000"},{"label":"Effective","value":"2024-02-28"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}